Investigating the effects of two novel 4-MMPB analogs as potent lipoxygenase inhibitors for prostate cancer treatment.

Sonia IranpourAseel Kamil Mohammed Al-MosawiAhmad Reza BahramiHamid SadeghianMaryam M Matin

Published in: Journal of biological research (Thessalonike, Greece) (2021)

Thus, our results suggest that specific targeting of lipoxygenases via 4-MMPB analogs can be considered as a treatment of choice for PC therapy, although it requires further investigations.

Keyphrases

prostate cancer
molecular docking
stem cells
combination therapy
drug delivery
replacement therapy
mesenchymal stem cells
cell therapy